-
Share
4,710 Posts.
1097
26/03/21
23:58
Share
Wow!
Did Mark just confirm that Prof. Voit is going to be our “PI” for the EMA trial?
i.e. Principle Investigator
If so, then get ready for one big trial covering EMA and FDA programs....that will include combination therapy arm with Sarepta.
The Professor was very excited by the P2 results in his video interview with Shane Storey.
He also owns the ‘microdystrophin’ IP Sarepta are using.
Win win.
Last edited by
Uboy:
26/03/21
-
